Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retrobulbar Methylprednisolone in Optic Neuritis
NCT04942002Phase 3Unknown
- Sponsor
- Asociación para Evitar la Ceguera en México
- Start
- Jun 2021
- Primary completion
- Jun 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methylprednisolone in optic neuritis (ON), sponsored by Asociación para Evitar la Ceguera en México. Status: unknown.
02
Drugs
methylprednisolone
03
Conditions
optic neuritis (ON)
Beyond the preview
Go deeper on NCT04942002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04942002.